4.7 Editorial Material

Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease One Step Closer to the Clinical Scenario

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome

Miriam Diez-Diez et al.

Summary: Clonal hematopoiesis of indeterminate potential (CHIP), the presence of somatic mutations in cancer-related genes in blood cells without hematological cancer, is an important risk factor for age-related conditions, especially cardiovascular disease. It is unknown whether CHIP plays a role in premature aging syndromes. Hutchinson-Gilford progeria syndrome (HGPS) is an ultra-rare genetic condition characterized by accelerated aging. This study investigated the prevalence of CHIP in HGPS patients and found that it is not frequent in HGPS, suggesting that it is unlikely to contribute to the pathophysiology of this accelerated aging syndrome.

GEROSCIENCE (2023)

Article Cardiac & Cardiovascular Systems

Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease

Esra D. Gumuser et al.

Summary: This study examined the prognostic value of clonal hematopoiesis of indeterminate potential (CHIP) in individuals with established atherosclerotic cardiovascular disease (ASCVD). The results showed that any CHIP and large CHIP were associated with adverse outcomes, with TET2 and spliceosome CHIP having the strongest associations.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab An Exploratory Analysis of the CANTOS Randomized Clinical Trial

Eric C. Svensson et al.

Summary: This study investigated whether individuals with CHIP have a greater reduction in cardiovascular events in response to IL-1 beta neutralization therapy.

JAMA CARDIOLOGY (2022)

Article Multidisciplinary Sciences

Common and rare variant associations with clonal haematopoiesis phenotypes

Michael D. Kessler et al.

Summary: Clonal haematopoiesis, associated with ageing and adverse health outcomes, involves the expansion of certain blood cell lineages. This study identified novel germline genetic variations influencing predisposition to clonal haematopoiesis using exome sequence data from over 600,000 individuals. The study also found associations between clonal haematopoiesis and severe COVID-19 outcomes, cardiovascular disease, and malignancy.

NATURE (2022)

Article Cardiac & Cardiovascular Systems

Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock

Fernando L. Scolari et al.

Summary: This study found that cardiogenic shock patients have a high prevalence of clonal haematopoiesis (CH), particularly mutations in TET2 and ASXL1, which are associated with reduced survival and dysregulation of circulating inflammatory cytokines in these patients.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Impact of Clonal Hematopoiesis in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction

Matthias Boehme et al.

Summary: In patients with AMI complicating CS, CHIP is common and associated with poor clinical outcomes, suggesting that CHIP assessment could aid in risk stratification and identifying novel treatment targets.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Article Endocrinology & Metabolism

Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution

Patrick B. Ampomah et al.

Summary: This study demonstrates that methionine derived from apoptotic cells taken up by macrophages during efferocytosis plays a role in mediating tissue resolution by providing a substrate for DNA methylation and repressing the expression of the ERK1/2 phosphatase Dusp4, leading to activation of ERK1/2 and the expression of pro-resolving mediators.

NATURE METABOLISM (2022)

Article Cardiac & Cardiovascular Systems

Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations

Birgit Assmus et al.

Summary: Somatic mutations of DNMT3A and TET2 in patients with chronic ischaemic heart failure were found to be associated with clonal haematopoiesis and poor prognosis. The study defined threshold levels for these mutations, indicating a worse outcome in patients with higher variant allele frequencies.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction

Domingo A. Pascual-Figal et al.

Summary: This study found that clonal hematopoiesis mutations are common among HF patients with reduced LVEF and are associated with accelerated HF progression, regardless of whether the etiology is ischemic or nonischemic.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management

Devinder S. Dhindsa et al.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic lschemic Heart Failure

Lena Dorsheimer et al.

JAMA CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors

Leticia Fernandez-Friera et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Medicine, General & Internal

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease

S. Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)